Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

Endometrial Biopsy in Infertile Patients

ClinicalTrials.gov ID: NCT00064935

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00064935. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 8:25 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Utility of the Endometrial Biopsy in the Evaluation of the Luteal Phase

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

When a woman becomes pregnant, the fertilized egg attaches itself to the lining of the uterus (endometrium). The endometrium is constantly changing throughout a woman's menstrual cycle in response to the female hormones estrogen and progesterone. The endometrium must have certain characteristics (be at a specific phase in its cycle) in order for the fertilized egg to successfully attach. Infertility may be caused by an "out of phase" endometrium (i.e., the endometrium doesn't have the right characteristics when the fertilized egg reaches it). The purpose of this study is to evaluate whether the endometrial biopsy is useful in predicting the potential for becoming pregnant and bearing a child.

Study identification

NCT ID
NCT00064935
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
880 participants

Conditions and interventions

Conditions

Interventions

Procedure

Eligibility (public fields only)

Age range
25 Years to 39 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1999 (Type not available)
Primary completion
Not listed
Completion
Feb 2002 (Type not available)
Last update posted
Jun 24, 2005

1999 – 2002

United States locations

U.S. sites
8
U.S. states
6
U.S. cities
8
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35249 —
University of Colorado Denver Colorado 80262 —
Wayne State University Detroit Michigan 48201 —
University of Medicine and Dentistry, NJ Newark New Jersey 07103 —
Pennsylvania State University Hershey Pennsylvania 17033 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Baylor College of Medicine Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00064935, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2005 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.